What is Addison's Disease
Addison's disease is primary adrenal insufficiency resulting from damage to the adrenal cortex, causing inadequate production of cortisol and aldosterone hormones, regardless of the underlying cause. 1
Epidemiology and Prevalence
- The disease affects approximately 10-15 per 100,000 population, making it a rare condition. 1
- In Western Europe, autoimmunity accounts for approximately 85% of cases after excluding congenital adrenal hyperplasia. 1
- Tuberculosis, adrenal hemorrhage, and genetic disorders comprise the remaining causes. 1
Pathophysiology
- The condition results from destruction of the adrenal cortex, the region responsible for hormone synthesis. 2
- This disrupts the hypothalamic-pituitary-adrenal (HPA) axis, leading to cortisol deficiency which is critical for regulating metabolism, immune function, and stress responses. 2
- Aldosterone deficiency causes dysregulation of sodium and potassium homeostasis, resulting in hypotension and dehydration. 2
- Patients also lose adrenal androgen production (DHEA, androstenedione), which is particularly significant in women as the adrenal glands are their primary androgen source. 3
Clinical Presentation
- Symptoms develop insidiously over months to years and are often nonspecific. 1, 4
- Common manifestations include persistent fatigue, muscle weakness (myasthenia), unintentional weight loss, hypotension, and salt craving. 5, 2
- Hyperpigmentation of the skin occurs, especially in areas subjected to friction, due to elevated ACTH levels. 2, 6
- Additional symptoms include malaise, anorexia, and nausea. 7
- Symptoms typically do not appear until most of the adrenal gland has been destroyed. 7
Laboratory Findings
- Hyponatremia is present in 90% of newly diagnosed cases. 1, 5
- Hyperkalaemia occurs in approximately 50% of cases. 5
- Low serum cortisol and elevated plasma ACTH levels are characteristic. 5
- The classical combination of hyponatremia and hyperkalaemia is not always reliable for diagnosis. 1
Associated Autoimmune Conditions
- Approximately 50% of patients with autoimmune Addison's disease have other co-existing autoimmune diseases. 1, 5
- Common associations include autoimmune thyroid disease, autoimmune gastritis with vitamin B12 deficiency, type 1 diabetes mellitus, premature ovarian insufficiency, vitiligo, and coeliac disease. 1
- Autoimmune polyendocrine syndrome type-1 (APS-1) is defined by the combination of two of three components: primary adrenal insufficiency, hypoparathyroidism, and chronic mucocutaneous candidiasis. 1, 5
- Autoimmune polyendocrine syndrome type-2 (APS-2) most commonly involves primary adrenal insufficiency with primary hypothyroidism, but can include Graves' disease, autoimmune gastritis, and type 1 diabetes. 1, 5
Historical Context and Prognosis
- Prior to the 1940s, Addison's disease was always fatal. 1
- The synthesis of corticosteroids by Kendall and Reichstein made life-saving treatments possible and transformed it into a fully treatable chronic condition. 1
- With proper treatment, Addison's disease is now a manageable chronic condition. 5
- However, premature death from adrenal crises remains a risk, and patients face therapy-related complications including osteoporosis and cardiovascular disease. 1, 5
- Quality of life and ability to work is reduced in many patients. 1